Report cover image

Kidney Transplant Market - 2025-2033

Published Mar 26, 2026
Length 217 Pages
SKU # DTAM21123430

Description

Kidney Transplant Market Overview:
The Kidney Transplant Market was valued at US$ 8.86 Billion in 2025 and is anticipated to reach US$ 15.49 Billion by 2033, at a CAGR of 0.0765 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Kidney Transplant Market.

This report delivers a comprehensive overview of the Kidney Transplant Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Kidney Transplant Market. The Kidney Transplant Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

Kidney Transplant Market Scope:
Key Players
• Novartis AG
• Astellas Pharma Inc.
• Sanofi S.A.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd.
• Medtronic
• BioLife Solutions, Inc.(LIST NOT EXHAUSTIVE)

Major Highlights
This report delivers a comprehensive overview of the Kidney Transplant Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Kidney Transplant Market. The Kidney Transplant Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

217 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
3. Market Highlights and Strategic Takeaways
3.1. Key Trends and Future Projections
3.2. Snippet by Product
3.2.1. Snippet by Transplant Type
3.2.2. Snippet by Preservation Method
3.2.3. Snippet by Age Group
3.2.4. Snippet by End User
3.2.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of kidney diseases
4.1.1.2. Increased healthcare expenditure and government initiatives
4.1.1.3. Growing awareness and education
4.1.2. Restraints
4.1.2.1. High cost of transplantation
4.1.2.2. Organ shortage and waiting list challenges
4.1.2.3. Ethical and Legal Considerations
4.1.3. Opportunity
4.1.3.1. Technological innovations
4.1.3.2. Organ Procurement and Allocation System Improvements
4.1.4. Impact Analysis
5. Strategic Insights and Industry Outlook
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with largest largest-selling Brand
5.1.3. Market leaders with established products & Services
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Force Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics
6. Global Kidney Transplant Market, By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Preservation and Storage Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Perfusion Systems
6.2.4. Cold Storage Boxes
6.2.5. Transport Containers
6.3. Surgical Equipment
6.4. Dialysis Equipment
6.5. Other Consumables
7. Global Kidney Transplant Market, By Transplant Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplant Type
7.1.2. Market Attractiveness Index, By Transplant Type
7.2. Living Donor Transplant*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Paired Kidney Transplant
7.4. Deceased Donor Transplant
8. Global Kidney Transplant Market, By Preservation Method
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Preservation Method
8.1.2. Market Attractiveness Index, By Preservation Method
8.2. Hypothermic Machine Perfusion (HMP)*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Static Cold Storage (SCS)
8.4. Normothermic Machine Perfusion (NMP)
8.5. Others
9. Global Kidney Transplant Market, By Age Group
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.1.2. Market Attractiveness Index, By Age Group
9.2. Children*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Adult
9.4. Geriatrics
10. Global Kidney Transplant Market, By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Transplant Centers
10.5. Others
11. Global Kidney Transplant Market Regional Market Analysis and Growth Opportunities
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplant Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Preservation Method
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. U.S.
11.2.8.2. Canada
11.2.8.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplant Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Preservation Method
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. U.K.
11.3.8.3. France
11.3.8.4. Spain
11.3.8.5. Italy
11.3.8.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplant Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Preservation Method
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Brazil
11.4.8.2. Argentina
11.4.8.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplant Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Preservation Method
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. South Korea
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplant Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Preservation Method
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape and Market Positioning
12.1. Competitive Overview and Key Market Players
12.2. Market Share Analysis and Positioning Matrix
12.3. Strategic Partnerships, Mergers & Acquisitions
12.4. Key Developments in Product Portfolios and Innovations
12.5. Company Benchmarking
13. Company Profiles
13.1. Novartis AG*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
13.1.3. Financial Overview
13.1.3.1. Company Revenue
13.1.3.2. Geographical Revenue Shares
13.1.3.3. Revenue Forecasts
13.1.4. Key Developments
13.1.4.1. Mergers & Acquisitions
13.1.4.2. Key Product Development Activities
13.1.4.3. Regulatory Approvals, etc.
13.1.4.4. SWOT Analysis
13.2. Astellas Pharma Inc.
13.3. Sanofi S.A.
13.4. Pfizer Inc.
13.5. F. Hoffmann-La Roche Ltd
13.6. AbbVie Inc.
13.7. Bristol-Myers Squibb Company
13.8. Teva Pharmaceutical Industries Ltd.
13.9. Medtronic
13.10. BioLife Solutions, Inc.(LIST NOT EXHAUSTIVE)
14. Assumptions and Research Methodology
14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation
15. Appendix
15.1. About Us and Services
15.2. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.